Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.

Schrickel, Jan W

Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation. [electronic resource] - Clinical research in cardiology : official journal of the German Cardiac Society Feb 2016 - 95-105 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1861-0692

10.1007/s00392-015-0933-1 doi


Administration, Oral
Anticoagulants--administration & dosage
Atrial Fibrillation--complications
Catheter Ablation--methods
Dabigatran--administration & dosage
Hemorrhage--chemically induced
Humans
Intracranial Embolism--etiology
Prospective Studies
Pulmonary Veins--surgery
Research Design